Systemic Therapeutics Corp. is a Canadian pre-clinical stage, biotechnology company specialized in the development of new therapies focusing on the master regulator of lipid metabolism, sterol regulatory-element binding proteins (SREBP), based on first-in-class small molecule SREBP inhibitors. The company aims to provide new treatment options for metabolic conditions such as dyslipidemia, via reduction of circulating PCSK9, and Non-Alcoholic Fatty Liver Disease. Systemic is pioneering a new approach to the care of metabolic disorders.
Co-Founder, Executive Chairman and Chief Scientific Officer
Co-Founder and Vice President, Drug Discovery
Co-Founder and Chief Medical Officer
Co-Founder and Vice President, Business Development
Intellectual Property
Fundraising
Our website uses cookies to ensure you get the best experience. Learn more about the policy.
Are you developing and/or redesigning new green products, services, processes, and technologies that reduce environmental impact?
The i.d.e.a.™ Fund program focuses on supporting a more sustainable economy while fostering an inclusive and equitable growth in southern Ontario. Find out if you’re eligible to access up to $20,000 in matching seed funding and 30 hours of expert mentorship.
Applications are open from June 16 to July 7, 2025.
Since 2011, we’ve helped over 160 startups launch and scale their businesses. This fall, network with 350+ entrepreneurs, investors, and leaders at a milestone evening where community, growth & collaboration meet innovation.
Meet the top 10 finalists, and watch as they pitch their innovations live to a panel of investors and experts for cash prizes!
When: September 25, 2025 | 5:00pm – 9:00pm
Where: Oakville Banquet & Conference Centre |
2515 Wyecroft Rd, Oakville, ON L6L 6P8
